Vivos (RDGL) Revenue (QoQ) (2010 - 2025)
Analysis
Vivos (RDGL) Revenue (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1,217.30% |
| Sep 30, 2025 | -87.47% |
| Jun 30, 2025 | -43.92% |
| Mar 31, 2025 | 435.50% |
| Dec 31, 2024 | -0.10% |
| Sep 30, 2024 | -62.96% |
| Jun 30, 2024 | 200.00% |
| Sep 30, 2023 | 7.69% |
| Jun 30, 2023 | 8.33% |
| Mar 31, 2023 | -7.68% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -38.10% |
| Jun 30, 2022 | -19.23% |
| Dec 31, 2019 | -81.25% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Jun 30, 2014 | -28.46% |
| Mar 31, 2013 | -62.81% |
| Dec 31, 2012 | 2.22% |
| Sep 30, 2012 | 0.00% |